Arrhythmias & electrophysiology

Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China: The ChiCSP Study

JACC Clin ElectrophysiolPublished prospective registry-based study

Authors' conclusion

CSP demonstrated long-term safety and stability. Subclassification of LBBAP enhances clinical precision, with LBBP capture yielding a higher positive clinical outcomes and LVSP with inferior outcomes, especially in cardiac resynchronization therapy patients.

Study context

Population
Patients receiving conduction system pacing at Chinese centers from 2019 to 2021enrolled, 3,167 successfully received conduction system pacing (CSP) · His bundle pacing (HBP) 557 · left bundle branch area pacing (LBBAP) 2,610
Participants
3,336 patients
Exposure
HBP vs LBBAP, and LBBAP subclasses
  • HBPn = 557
  • LBBAPn = 2,610
Methodological details5 Chinese centers, multicenter
  • 5 Chinese centers
  • Multicenter

Main finding

As reported in the abstract

LVEF improvement in patients with LBBB and heart failure with reduced ejection fraction

Left bundle branch pacing (LBBP)

+20.7%

HBP

+21.9%

Left ventricular septal pacing (LVSP)

+12.1%

Observational data: associations, not effects.

Further findings

OutcomeValues
Mortality or heart failure hospitalizationLVSP 33.3% · LBBP 8.6% · unclassified LBBAP 15.4%
Follow-up and LBBAP classificationLBBP share of LBBAP 84.2% · unclassified LBBAP share of LBBAP 12.5% · LVSP share of LBBAP 3.3%
Follow-up and LBBAP classification — mean follow-up
41.3 ± 14.0 months

Safety

OutcomeValuesP value
Threshold increases ≥1 V/0.5 msHBP 5.03% · LBBAP 1.80%P < 0.001
Procedural complications (excluding threshold rise)HBP 1.3% · LBBAP 1.3%

Original publication

Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China: The ChiCSP Study. JACC Clin Electrophysiol. Published 19 March 2026. doi:10.1016/j.jacep.2026.01.037

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.